203 related articles for article (PubMed ID: 8082940)
1. Differential regulation of natriuretic peptide receptor activity in vascular cells.
Cao L; Zlock DW; Gardner DG
Hypertension; 1994 Sep; 24(3):329-38. PubMed ID: 8082940
[TBL] [Abstract][Full Text] [Related]
2. Expression of guanylyl cyclase-A/atrial natriuretic peptide receptor blocks the activation of protein kinase C in vascular smooth muscle cells. Role of cGMP and cGMP-dependent protein kinase.
Kumar R; Cartledge WA; Lincoln TM; Pandey KN
Hypertension; 1997 Jan; 29(1 Pt 2):414-21. PubMed ID: 9039136
[TBL] [Abstract][Full Text] [Related]
3. Thrombin inhibits atrial natriuretic peptide receptor activity in cultured bovine endothelial cells.
Zlock DW; Cao L; Wu J; Gardner DG
Hypertension; 1997 Jan; 29(1 Pt 1):83-90. PubMed ID: 9039085
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of natriuretic peptide receptors on ciliary body epithelial cells.
Crook RB; Chang AT
Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):49-55. PubMed ID: 9164840
[TBL] [Abstract][Full Text] [Related]
5. Natriuretic peptide clearance receptor is transcriptionally down-regulated by beta 2-adrenergic stimulation in vascular smooth muscle cells.
Kishimoto I; Yoshimasa T; Suga S; Ogawa Y; Komatsu Y; Nakagawa O; Itoh H; Nakao K
J Biol Chem; 1994 Nov; 269(45):28300-8. PubMed ID: 7961768
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of C-receptor by natriuretic peptides via ANP-B receptor in vascular smooth muscle cells.
Kishimoto I; Nakao K; Suga S; Hosoda K; Yoshimasa T; Itoh H; Imura H
Am J Physiol; 1993 Oct; 265(4 Pt 2):H1373-9. PubMed ID: 8238425
[TBL] [Abstract][Full Text] [Related]
7. Regulation of secretion and clearance of C-type natriuretic peptide in the interaction of vascular endothelial cells and smooth muscle cells.
Komatsu Y; Itoh H; Suga S; Igaki T; Ogawa Y; Kishimoto I; Nakagawa O; Yoshimasa T; Nakao K
J Hypertens; 1996 May; 14(5):585-92. PubMed ID: 8762201
[TBL] [Abstract][Full Text] [Related]
8. Atrial natriuretic peptide binding, cross-linking, and stimulation of cyclic GMP accumulation and particulate guanylate cyclase activity in cultured cells.
Leitman DC; Andresen JW; Catalano RM; Waldman SA; Tuan JJ; Murad F
J Biol Chem; 1988 Mar; 263(8):3720-8. PubMed ID: 2894373
[TBL] [Abstract][Full Text] [Related]
9. Regulation of atrial natriuretic peptide receptors in vascular smooth muscle cells: role of cGMP.
Zhang LM; Tao H; Newman WH
Am J Physiol; 1993 Jun; 264(6 Pt 2):H1753-9. PubMed ID: 8391754
[TBL] [Abstract][Full Text] [Related]
10. Phenotype-related alteration in expression of natriuretic peptide receptors in aortic smooth muscle cells.
Suga S; Nakao K; Kishimoto I; Hosoda K; Mukoyama M; Arai H; Shirakami G; Ogawa Y; Komatsu Y; Nakagawa O
Circ Res; 1992 Jul; 71(1):34-9. PubMed ID: 1318796
[TBL] [Abstract][Full Text] [Related]
11. Identification, regulation and anti-proliferative role of the NPR-C receptor in gastric epithelial cells.
Gower WR; Carter GM; McAfee Q; Solivan SM
Mol Cell Biochem; 2006 Dec; 293(1-2):103-18. PubMed ID: 16786190
[TBL] [Abstract][Full Text] [Related]
12. Regulation of natriuretic peptide receptor A and B expression by transforming growth factor-beta 1 in cultured aortic smooth muscle cells.
Fujio N; Gossard F; Bayard F; Tremblay J
Hypertension; 1994 Jun; 23(6 Pt 2):908-13. PubMed ID: 7911451
[TBL] [Abstract][Full Text] [Related]
13. C-type natriuretic Peptide down-regulates expression of its cognate receptor in rat aortic smooth muscle cells.
Rahmutula D; Gardner DG
Endocrinology; 2005 Nov; 146(11):4968-74. PubMed ID: 16109786
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic peptide-C receptor-induced attenuation of adenylyl cyclase signaling activates phosphatidylinositol turnover in A10 vascular smooth muscle cells.
Mouawad R; Li Y; Anand-Srivastava MB
Mol Pharmacol; 2004 Apr; 65(4):917-24. PubMed ID: 15044621
[TBL] [Abstract][Full Text] [Related]
15. Modulation by NaCl of atrial natriuretic peptide receptor levels and cyclic GMP responsiveness to atrial natriuretic peptide of cultured vascular endothelial cells.
Katafuchi T; Mizuno T; Hagiwara H; Itakura M; Ito T; Hirose S
J Biol Chem; 1992 Apr; 267(11):7624-9. PubMed ID: 1348507
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of protein kinase C potentiates atrial natriuretic peptide-stimulated cGMP accumulation in vascular smooth-muscle cells.
Kawabe J; Ohsaki Y; Onodera S
Biochim Biophys Acta; 1992 Dec; 1175(1):81-7. PubMed ID: 1362357
[TBL] [Abstract][Full Text] [Related]
17. Difference in effect of atrial natriuretic peptide on cGMP in aortic and coronary smooth muscle cells.
Newman WH; Kato J; Becker BF; Currie MG
Am J Physiol; 1992 Sep; 263(3 Pt 2):H710-4. PubMed ID: 1329536
[TBL] [Abstract][Full Text] [Related]
18. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.
Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H
Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060
[TBL] [Abstract][Full Text] [Related]
19. Cyclic adenosine monophosphate (cAMP) increases natriuretic peptide receptor C (NPR-C) expression in human aortic smooth muscle cells.
Puggina E; Sellitti D
Mol Cell Endocrinol; 2004 Apr; 219(1-2):161-9. PubMed ID: 15149737
[TBL] [Abstract][Full Text] [Related]
20. Cyclic GMP down-regulates atrial natriuretic peptide receptors on cultured vascular endothelial cells.
Kato J; Lanier-Smith KL; Currie MG
J Biol Chem; 1991 Aug; 266(22):14681-5. PubMed ID: 1650366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
